Severe preeclampsia and high frequency of genetic thrombophilic mutations

Obstetrics and Gynecology

Volumn 96, Issue 1, 2000, Pages 45-49

  Kupferminc, M J ^a   Fait, G ^a   Many, A ^a   Gordon, D ^a   Eldor, A ^b   Lessing, J B ^a  

^a LIS MATERNITY HOSPITAL   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOPHILIA;

ADULT; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; MUTATION; PRE-ECLAMPSIA; PREGNANCY; THROMBOPHILIA;

EID: 0034079143     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00861-9     Document Type: Article

References (31)

1. Saftlas A.F., Olson D.R., Franks A.L., Atrash H., Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 163:1990;460-465.
2. Roberts J.M., Taylor R.N., Musici T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia An endothelial cell disorder . Am J Obstet Gynecol. 161:1989;1200-1204.
3. Salafia C.M., Pezzulo J.C., Lopez-Zeno J.A., Minior V.K., Vintzileos A.M. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol. 173:1995;1079-1105.
4. Shanklin D.R., Sibai B.M. Ultrastructural aspects of preeclampsia. Am J Obstet Gynecol. 161:1989;735-741.
5. Khong T.Y., Pearce J.M., Robertson W.B. Acute atherosis in preeclampsia Maternal determinants and fetal outcome in the presence of the lesion . Am J Obstet Gynecol. 157:1987;360-363.
6. Dahlback B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis. 24:1994;139-151.
7. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
8. Svensson P.J., Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 330:1994;517-522.
9. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease A common mutation in methylenetetrahydrofolate reductase . Nat Genet. 10:1995;111-113.
10. Kluijtmans L.A., van den Heuvel L.P., Boers G.H., Frosst P., Stevens E.M., van Oost B.A., et al. Molecular genetic analysis in mild hyperhomocystinemia A common mutation in the methylene-tetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease . Am J Hum Genet. 58:1996;35-41.
11. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:1996;3698-3703.
12. Rosendaal F.R., Siscovick D.S., Schwartz S.M., Psaty B.M., Raghunathan T.E., Vos H.L. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood. 90:1997;1747-1750.
13. Martinelli I., Sacchi E., Landi G., Taioli E., Duca F., Mannucci P.M. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 338:1998;1793-1797.
14. Dekker G.A., de Vries J.I., Doelitzsch P.M., Huijgens P.C., von Blomberg B.M., Jakobs C., et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 173:1995;1042-1048.
15. Dizon-Townson D.S., Nelson L.M., Easton K., Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol. 175:1996;902-905.
16. Lindoff C., Ingemarsson I., Martinsson G., Segelmark M., Thysell H., Astedt B. Preeclampsia is associated with reduced response to activated protein C. Am J Obstet Gynecol. 176:1997;457-460.
17. Van Pampus M.G., Dekker G.A., Wolf H., Huijgens P.C., Koopman M.M.W., von Blomberg B.M., et al. High prevalence of hemostatic abnormalities in women with a history of preeclampsia. Am J Obstet Gynecol. 180:1999;1146-1150.
18. Rajkovic A., Catlano P.M., Malinow M.R. Elevated homocysteine levels with preeclampsia. Obstet Gynecol. 90:1997;168-171.
19. Grandone E., Margaglione M., Colaizzo D., Cappucci G., Paladini D., Martinelli P., et al. Factor V Leiden, C T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost. 77:1997;1052-1054.
20. Sohda S., Arinami T., Hamada H.M., Yamada N., Hamaguchi H., Kubo T. Methylenetetrahydrofolate reductase polymorphism and preeclampsia. J Med Genet. 34:1997;525-526.
21. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 340:1999;9-13.
22. Hypertension in pregnancy. ACOG technical bulletin no. 219. 1996;American College of Obstetricians and Gynecologists, Washington DC.
23. Brenner W.E., Edelman D.A., Hendricks C.H. A standard of fetal growth for the United States of America. Am J Obstet Gynecol. 126:1976;555-564.
24. Nagy B., Toth T., Rigo J. Jr, Karadi I., Romics L., Papp Z. Detection of factor V Leiden mutation in severe preeclamptic Hungarian women. Clin Genet. 53:1998;478-481.
25. O'Shaughnessy K.M., Fu B., Ferraro F., Lewis I., Downing S., Morris N.H. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension. 33:1999;1338-1341.
26. Powers R.W., Minich L.A., Lykins D.L., Ness R.B., Crombleholme W.R., Roberts J.M. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig. 6:1999;74-79.
27. Rees D.C., Cox M., Clegg J.B. World distribution of factor V Leiden. Lancet. 346:1995;1133-1134.
28. Kang S.S., Zhou J., Wong P.W.K., Kowalisyn J., Strokosch G. Thermolabile methylenetetrahydrofolate reductase An inherited risk factor for coronary artery disease . Am J Hum Genet. 48:1991;536-545.
29. Seligsohn U., Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemostas. 78:1997;297-301.
30. Molloy A.M., Daly S., Mills J.L., Kirke P.N., Whitehead A.S., Ramsbottom D., et al. Thermolabile variant of 5,10 methylenetetrahydrofolate reductase associated with low red-cell folates Implications for folate intake recommendations . Lancet. 349:1997;1591-1593.
31. Caritis S., Sibai B., Hauth J., Lindheimer M.D., Klebanoff M., Thom E., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med. 338:1998;701-705.